American Journal of Cancer Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2021-11-13 ms3000001370941770

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊

65 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-09-22 ms4000000007443247 来自四川省

友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-08-05 shademei 来自河北省

偏重的研究方向：肿瘤学
经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的

0 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-09-25 ms4000000418941187 来自广东省

偏重的研究方向：肿瘤基础研究;肿瘤
经验分享：Submit快5天了，还是under review，是不是已经送审了呀？

26 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-05-24 gaogao 来自广东省

审稿速度:2.0
偏重的研究方向：肿瘤
经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友

30 32

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-08-20 Cynthia开心来自北京

under review 后面写的unpaid 是正常的吗

26 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-07-24 DAIJIAZHENG 来自江苏省

这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-07-26 科研小帮来自广西

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：肿瘤方向

26 0

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-07-25 DAIJIAZHENG 来自江苏省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：科;妇;产
经验分享：审稿意见专业。不容易中

23 0

[GetPortalCommentsPageByObjectIdResponse(id=1069902, encodeId=fe3a1069902ce, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一个月前投了这个杂志，今天发现当时没给我发投稿成功的邮件，网站是显示Under review状态，这样是投稿成功吗？好慌啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28d5650878, createdName=ms3000001370941770, createdTime=Sat Nov 13 15:36:02 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2159200, encodeId=689f2159200b1, content=友友们，投稿后没有收到邮件是怎么回事呢？有人遇到过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5d5b5549129, createdName=ms4000000007443247, createdTime=Fri Sep 22 22:11:34 CST 2023, time=2023-09-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2151352, encodeId=4070215135253, content=偏重的研究方向：肿瘤学 经验分享：这杂志online 好慢，版面费倒是不算贵，invoice交完费，大概一个多月才online,而且没通知，是我自己查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Aug 05 01:10:03 CST 2023, time=2023-08-05, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2159610, encodeId=751d215961008, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：Submit快5天了，还是under review，是不是已经送审了呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce85486753, createdName=ms4000000418941187, createdTime=Mon Sep 25 17:06:28 CST 2023, time=2023-09-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2153740, encodeId=23862153e40b6, content=under review 后面写的unpaid 是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Sun Aug 20 16:22:28 CST 2023, time=2023-08-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149658, encodeId=515e214965849, content=这个杂志现在挺难中的，审稿非常严格，提的相关的问题都挺专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Mon Jul 24 22:36:28 CST 2023, time=2023-07-24, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149913, encodeId=785a2149913b0, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：肿瘤方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Wed Jul 26 11:24:31 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2149688, encodeId=61522149688bb, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：科;妇;产 经验分享：审稿意见专业。不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:55 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2149687, encodeId=fbce214968ef5, content=这个杂志意见挺专业的，不太容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=49261445673, createdName=DAIJIAZHENG, createdTime=Tue Jul 25 06:14:08 CST 2023, time=2023-07-25, status=1, ipAttribution=江苏省)]

2023-07-25 DAIJIAZHENG 来自江苏省

这个杂志意见挺专业的，不太容易中

29 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务